Rankings
▼
Calendar
VSTM Q1 2020 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+202.6% YoY
Gross Profit
$4M
82.5% margin
Operating Income
-$26M
-521.3% margin
Net Income
-$38M
-751.4% margin
EPS (Diluted)
$-4.22
QoQ Revenue Growth
+39.8%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$34M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$208M
Total Liabilities
$85M
Stockholders' Equity
$123M
Cash & Equivalents
$135M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$2M
+202.6%
Gross Profit
$4M
$1M
+271.9%
Operating Income
-$26M
-$35M
+24.0%
Net Income
-$38M
-$38M
+0.3%
Revenue Segments
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$950,000
66%
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$239,000
16%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$137,000
9%
Product Revenue And Allowances Returns
$123,000
8%
← FY 2020
All Quarters
Q2 2020 →